A Grin, Afazol CEP of the European Pharmacopoeia monograph is often referred to as a Grin, Afazol Certificate of Suitability (COS). The purpose of a Grin, Afazol CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Grin, Afazol EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Grin, Afazol to their clients by showing that a Grin, Afazol CEP has been issued for it. The manufacturer submits a Grin, Afazol CEP (COS) as part of the market authorization procedure, and it takes on the role of a Grin, Afazol CEP holder for the record. Additionally, the data presented in the Grin, Afazol CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Grin, Afazol DMF.
A Grin, Afazol CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Grin, Afazol CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Grin, Afazol suppliers with CEP (COS) on PharmaCompass.